AGP Executive Report
Last update: 2 hours agoRheumatology Access Crunch in Poland: Poland’s rheumatoid arthritis patients face mounting delays as hospitals’ fixed annual budgets for high-cost biological drug programmes run dry, leaving some newly eligible patients unable to start treatment even as demand grows. Hepatitis C Testing Push (UK, with Polish link): New NHS figures say 100,000+ people have been diagnosed and treated since 2015, and the NHS is urging free home testing for higher-risk groups—explicitly including adults born in Poland and other Eastern European countries. Healthcare Safety Spotlight (UK, Polish patient): A Polish-born man with type 1 diabetes died after receiving an “excessive dose” of insulin due to an unupdated prescription and missed specialist nursing review, raising concerns about discharge safety. Cyber Risk to Water Systems (Poland angle): Polish authorities named Russian actors in a water-hack prosecution, but said they couldn’t reach them—highlighting ongoing vulnerabilities in critical infrastructure. Medical Tech/Industry Note: Poland’s Ministry of Health reimbursement list includes toripalimab (LOQTORZI®), signaling continued expansion of covered oncology options.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
Pseudo-journalism: Pink-slime
